Notably, GBM tumours displayed markedly increased level of phosphorylated SHP2 and ERK followed by grade II gliomas in comparison to normal counterparts (Fig. 2f and Supplementary Fig. 4a). This evidence concerns the gene PTPN11 and central nervous system cancer.